Current Status of European Pharmaceutical Regulation

Since its inauguration, the European Medicines Agency has made great efforts to establish a harmonious pharmaceutical regulation procedure for the European community. However, it is almost impossible to develop a homogenous national pharmaceutical regime under EU law because each member state has a different pharmaceutical regulation procedure. Member states have each established their own method to regulate public healthcare while complying with commercial interests. In Europe, it is commonly held that governments should have the authority to regulate the cost value and profits of medicines. Because every country has its own regulatory procedure, pharmaceutical spending and government shares of total costs markedly differ. Due to current rising healthcare costs the disparity has greatly intensified, and this has made it even more difficult for policy-makers to limit Community influence and autonomy.

Main Menu

See Also

Main Menu